Glutathione‐Depleting Nanoenzyme and Glucose Oxidase Combination for Hypoxia Modulation and Radiotherapy Enhancement

Meng Lyu,Daoming Zhu,Xiangyue Kong,Yang Yang,Shuaijie Ding,Yunfeng Zhou,Hong Quan,Yanhong Duo,Zhirong Bao
DOI: https://doi.org/10.1002/adhm.201901819
IF: 10
2020-04-30
Advanced Healthcare Materials
Abstract:<p>Nanoenzymes perceive the properties of enzyme‐like catalytic activity, thereby offering significant cancer therapy potential. In this study, Fe<sub>3</sub>O<sub>4</sub>@MnO<sub>2</sub>, a magnetic field (MF) targeting nanoenzyme with a core‐shell structure, is synthesized and applied to radiation enhancement with using glucose oxidase (GOX) for combination therapy. The glucose is oxidized by the GOX to produce excess H<sub>2</sub>O<sub>2</sub> in an acidic extracellular microenvironment, following which the MnO<sub>2</sub> shell reacts with H<sub>2</sub>O<sub>2</sub> to generate O<sub>2</sub> and overcome hypoxia. Concurrently, intracellular glutathione (GSH)—which limits the effects of radiotherapy (RT)—can be oxidized by the MnO<sub>2</sub> shell while the latter is reduced to Mn<sup>2+</sup> for T<sub>1</sub>‐weighed MRI. The core Fe<sub>3</sub>O<sub>4</sub>, with its good magnetic targeting ability, can be utilized for T<sub>2</sub>‐weighed MRI. In summary, the work demonstrates that Fe<sub>3</sub>O<sub>4</sub>@MnO<sub>2</sub>, as a dual T<sub>1</sub>‐ and T<sub>2</sub>‐weighed MRI contrast agent with strong biocompatibility, exhibits striking potential for radiation enhancement under magnetic targeting.</p>
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?